Cardinal is using its own cyclotron installations to produce Gozellix for distribution across a range of US locations.

Cardinal Health (NYSE:CAH) has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development ...

TLX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.

Find insight on Microbix Biosystems, Lonza, China’s healthcare sector and more in the latest Market Talks covering the Health ...

Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...

As with the infamous Y2K computer bug, tariffs are shaping up largely as an irrelevance for US-exposed ASX biotechs.

Telix Pharmaceuticals says it does not expect any material impact on its business or supply chain as a result of ...

Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX). Gozellix® ...

The FDA has expanded Pluvicto's indication for PSMA-positive mCRPC patients post-ARPI therapy, delaying taxane-based chemotherapy. Selection for Pluvicto should be based on PSMA expression using ...